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During the 1950s, inmates at what was then called Holmes-
burg Prison, in Philadelphia, were 
inoculated with condyloma acu-
minatum, cutaneous moniliasis, 
and viruses causing warts, herpes 
simplex, and herpes zoster.1 For 
participating in this research, and 
in studies exposing them to diox-
in and agents of chemical warfare, 
they were paid up to $1,500 a 
month. Between 1963 and 1971, 
researchers in Oregon and Wash-
ington irradiated and repeatedly 
took biopsy specimens from the 
testicles of healthy prisoners; the 
men subsequently reported rash-
es, peeling, and blisters on the 
scrotum as well as sexual diffi-
culties.2 Hundreds of such exper-
iments induced the federal govern-
ment to essentially ban research 
involving prisoners in 1978. The 
message: such research is funda-
mentally exploitative and thus un-
ethical.
Yet a recent report by the Insti-
tute of Medicine (IOM) has opened 
the closed door, arguing not only 
that such research can be per-
formed appropriately but that pris-
oners deserve to be included in 
investigative studies — at least 
those who might benefit directly. 
Examination of the explanations 
behind U.S. restrictions on prison 
research and their current appli-
cability can provide guidance for 
today’s policy debates.
The vulnerability of prisoners 
to exploitation has long been 
known. As early as 1906, for in-
stance, critics noted how difficult 
it would have been for prisoners to 
refuse to participate in a cholera 
experiment that ultimately killed 
13 men.3 Still, investigators pe-
riodically sought out “volunteers” 
among such captive populations, 
whose institutionalization offered 
researchers accessible subjects un-
likely to be lost to follow-up.
Most such research did not seek 
to benefit participants. In 1915, 
for example, Public Health Service 
researcher Joseph Goldberger in-
duced pellagra in healthy Missis-
sippi prisoners, who were offered 
parole in exchange for participa-
tion. Those who signed up experi-
enced the very severe symptoms of 
the disease, including diarrhea, 
rash, and mental confusion.3 Gold-
berger, however, proved his hy-
pothesis that pellagra was a vita-
min-deficiency disease that could 
be cured by ingestion of the B vita-
min now known as niacin. Thanks 
to this work, as well as the discov-
ery of insulin and the first antimi-
crobial agents, the years between 
World War I and World War II 
were heady times for scientific re-
search.
World War II turned question-
able experimentation on prisoners 
into a cottage industry. As other 
Americans risked their lives on the 
battlefield, prisoners did their 
part by participating in studies 
that exposed them to gonorrhea, 
gas gangrene, dengue fever, and 
malaria.1 Any consideration of 
meaningful consent was sub-
sumed by the war imperative.
Ironically, the biggest boost to 
such experimentation came as a 
result of the postwar Nuremberg 
trial of 20 Nazi doctors, which 
gave rise to the Nuremberg Code, 
a set of principles intended to 
prohibit human experimentation 
without subjects’ consent. When 
defense lawyers implied that 
American scientists had conduct-
ed wartime research analogous 
to that of the Nazis, one prosecu-
tion witness, Andrew C. Ivy, cited 
malaria experiments involving Il-
linois prisoners as an example of 
“ideal,” noncoercive research. 
Ivy’s 1948 publication of his con-
clusions helped to institutional-
ize prison experimentation for 
the next quarter-century.4
It was an experiment involving 
another vulnerable population that 
halted the prison research enter-
prise. In 1972, an Associated Press 
reporter broke the story that poor 
southern black men with syphilis 
had been deliberately left untreated 
for 40 years so researchers could 
study the natural course of the dis-
ease. In the environment created by 
the civil rights movement and pro-
tests against the Vietnam War, 
such research was condemned. The 
scandal led to the formation of the 
National Commission for the Pro-
tection of Human Subjects of Bio-
medical and Behavioral Research 
and eventually the Belmont Report, 
which recommended revamping 
human experimentation using the 
principles of respect for persons, 
nonmaleficence, and justice.
In the case of prison research, 
the new atmosphere proved espe-
cially restrictive. In 1978, the De-
partment of Health and Human 
Services (DHHS) passed regula-
tions that limited federally funded 
research involving prisoners in 
several ways, stipulating, for ex-
ample, that experiments could 
pose no more than minimal risk 
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to the subjects. The overarching 
concern was that prisons were in-
herently coercive environments 
in which informed consent could 
never be obtained. The fact that 
research offered financial rewards, 
alleviation of boredom, and the 
prospect of earlier parole made 
it even more dicey.
This was the prevailing view 
until 2004, when the DHHS asked 
the IOM to revisit the matter. In 
August 2006 the IOM published 
its report, which acknowledged 
that it might make sense to leave 
the situation alone. For example, 
the U.S. prison population in-
cludes disproportionate numbers 
of vulnerable people: members of 
minority groups, the mentally ill, 
and persons with HIV infection 
and other serious infectious dis-
eases. Prisons are generally over-
crowded and have inadequate 
health care services. All these fac-
tors suggested that any easing of 
restrictions might lead to the rep-
etition of previous errors.
Nonetheless, the IOM panel, 
although sensitive to past “uncon-
scionable abuses,” recommended 
that experiments carrying more 
than minimal risk be allowed, 
with the caveat that studies in-
volving drugs or other biomedical 
interventions be required to have 
potential benefits for prisoners. 
The panel also recommended 
several safeguards, such as creat-
ing a public database of prison 
experiments, limiting research to 
interventions with some demon-
strated safety and efficacy, ensur-
ing that studies include a major-
ity of nonprisoner subjects, and 
requiring that proposals be vetted 
by institutional review boards that 
would include prisoner represen-
tatives.
The panel’s decision makes 
sense for several reasons. The first 
might be termed historical. For 
most of the 20th century, despite 
the findings at Nuremberg and 
occasional other warnings, hu-
man experimentation was largely 
seen as a “good,” something that 
would advance science and bene-
fit health. The backlash against 
experimentation in prisons oc-
curred during the 1970s, when 
authority was being questioned 
throughout society. No mecha-
nisms were in place to ensure the 
rights of vulnerable subjects. It 
thus made sense to ban any risky 
research in prisons.
It is often said that those who 
ignore history are condemned to 
repeat it. But a decision to retain 
current restrictions because of past 
abuses would ignore several im-
portant developments. Since 1978, 
a network of institutional review 
boards has been established at the 
National Institutes of Health, other 
governmental agencies, and re-
search universities throughout the 
country. With “informed consent” 
now common parlance, study sub-
jects are more aware of their 
rights. And, largely owing to the 
work of AIDS activists and breast 
cancer activists, sick and at-risk 
persons, even those from poten-
tially vulnerable populations, now 
actively pursue participation in re-
search protocols. Even though not 
all these developments are unam-
biguously positive, to ignore them 
and the opportunities they may af-
ford prisoners would be to regress. 
As the IOM report said, “Respect 
for prisoners also requires recog-
nition of their autonomy.”
Another argument in favor of 
relaxing restrictions is that the re-
flexive assumption that all prison 
research is problematic may not 
be accurate. In light of the abuses, 
critics have understandably ar-
gued that human experimentation 
in prison has failed because it 
takes place in a coercive environ-
ment that vitiates any possibility 
of informed consent. But that is a 
theory that can and should be in-
vestigated empirically through 
formal studies of the consent pro-
cess in prisons. Moreover, as phi-
losopher Carl Cohen has argued, 
research outside of prisons often 
has coercive elements as well — 
so to the degree that coercion is 
involved, it may have little to do 
with imprisonment.5
Finally, reinstituting and then 
monitoring prison research would 
afford society an opportunity for 
ongoing scrutiny and reassess-
ment. Indeed, the IOM panel found 
that much unregulated prison re-
search was being conducted despite 
the 1978 guidelines. Many of the 
notorious prison experiments in-
volved the active deception of study 
participants — an abuse more eas-
ily avoided if the whole enterprise 
is aboveboard. It is even possible 
that research studies, by providing 
a window into prison life, would 
focus needed attention on deficien-
cies in prison health care.
Still, the new regulations must 
be approached with trepidation. 
As sociologist Erving Goffman 
showed in his 1961 book Asylums, 
“total institutions” such as prisons 
may run roughshod over the rights 
of their inhabitants. Perhaps this 
book should be required reading 
for any investigator who embarks 
on research within prison walls.
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